Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ocugen
Pharma
Ocugen sniffs out COVID opportunity, landing nasal vaccine
Ocugen has secured regional rights to a nasal COVID-19 vaccine that already has emergency authorization in India.
Nick Paul Taylor
Oct 4, 2022 7:05am
Ocugen gets OK from FDA to resume trial of its COVID-19 vaccine
May 23, 2022 9:09am
The FDA says Ocugen needs to hand over results from a 2019 study
Apr 26, 2022 8:40am
Ocugen, Bharat get another clinical hold from FDA on COVID vax
Apr 12, 2022 4:03pm